Madrigal Pharmaceuticals total liabilities and share holders equity for the quarter ending December 31, 2024 was $1.042B, a 62.71% increase year-over-year.
Madrigal Pharmaceuticals total liabilities and share holders equity for 2024 was $1.042B, a 62.71% increase from 2023.
Madrigal Pharmaceuticals total liabilities and share holders equity for 2023 was $0.641B, a 76.67% increase from 2022.
Madrigal Pharmaceuticals total liabilities and share holders equity for 2022 was $0.363B, a 32.65% increase from 2021.
Madrigal Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2024 | MDGL